SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Almeida J.) srt2:(2015-2019)"

Sökning: WFRF:(Almeida J.) > (2015-2019)

  • Resultat 1-10 av 133
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Ruilope, LM, et al. (författare)
  • Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
  • 2019
  • Ingår i: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 50:5, s. 345-356
  • Tidskriftsartikel (refereegranskat)abstract
    • <b><i>Background:</i></b> Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. <b><i>Patients and</i></b> <b><i>Methods:</i></b> The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate ≥25 mL/min/1.73 m<sup>2</sup> and albuminuria (urinary albumin-to-creatinine ratio ≥30 to ≤5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level α = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. <b><i>Conclusions:</i></b> FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049.
  •  
10.
  • Aartsen, M. G., et al. (författare)
  • Very high-energy gamma-ray follow-up program using neutrino triggers from IceCube
  • 2016
  • Ingår i: Journal of Instrumentation. - 1748-0221 .- 1748-0221. ; 11
  • Tidskriftsartikel (refereegranskat)abstract
    • We describe and report the status of a neutrino-triggered program in IceCube that generates real-time alerts for gamma-ray follow-up observations by atmospheric-Cherenkov telescopes (MAGIC and VERITAS). While IceCube is capable of monitoring the whole sky continuously, high-energy gamma-ray telescopes have restricted fields of view and in general are unlikely to be observing a potential neutrino-flaring source at the time such neutrinos are recorded. The use of neutrino-triggered alerts thus aims at increasing the availability of simultaneous multi-messenger data during potential neutrino flaring activity, which can increase the discovery potential and constrain the phenomenological interpretation of the high-energy emission of selected source classes (e. g. blazars). The requirements of a fast and stable online analysis of potential neutrino signals and its operation are presented, along with first results of the program operating between 14 March 2012 and 31 December 2015.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 133
Typ av publikation
tidskriftsartikel (106)
konferensbidrag (17)
forskningsöversikt (9)
bokkapitel (1)
Typ av innehåll
refereegranskat (116)
övrigt vetenskapligt/konstnärligt (17)
Författare/redaktör
Bousquet, J (19)
Demoly, P. (19)
Mullol, J (19)
Bachert, C (18)
Bedbrook, A (18)
Haahtela, T (18)
visa fler...
Klimek, L (18)
Samolinski, B (18)
Ryan, D. (18)
Valovirta, E. (18)
Bewick, M (18)
Sheikh, A (17)
Zuberbier, T (17)
Kuna, P (17)
Kvedariene, V (17)
Devillier, P. (17)
Morais-Almeida, M. (17)
Valiulis, A. (17)
Keil, T (16)
Bindslev-Jensen, C (16)
Yorgancioglu, A (16)
Larenas-Linnemann, D (16)
Laune, D. (16)
Melen, E (15)
Kull, I (15)
Passalacqua, G (15)
Annesi-Maesano, I (15)
Just, J (15)
Fonseca, J (15)
Price, D. (14)
Wickman, M (14)
Arnavielhe, S (14)
Murray, R. (14)
Todo-Bom, A. (14)
Valero, A. (13)
Li, J. (13)
de Vries, G (13)
Pfaar, O (13)
van Eerd, M. (13)
Triggiani, M (13)
Zhang, L. (12)
Agache, I (12)
Illario, M. (12)
Menditto, E. (12)
Palkonen, S (11)
Stellato, C. (11)
Chavannes, N. H. (11)
Emuzyte, R. (11)
Custovic, A (11)
Malva, J (11)
visa färre...
Lärosäte
Karolinska Institutet (61)
Uppsala universitet (32)
Lunds universitet (13)
Stockholms universitet (12)
Göteborgs universitet (9)
Umeå universitet (8)
visa fler...
Kungliga Tekniska Högskolan (7)
Chalmers tekniska högskola (6)
Linnéuniversitetet (5)
Mälardalens universitet (4)
Linköpings universitet (4)
Malmö universitet (3)
RISE (2)
Luleå tekniska universitet (1)
Högskolan i Gävle (1)
Blekinge Tekniska Högskola (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (133)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (42)
Medicin och hälsovetenskap (42)
Samhällsvetenskap (9)
Teknik (7)
Lantbruksvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy